Journey Medical NASDAQ DERM Reports 21 Revenue Growth in Q1 2026 Remains Unprofitable Cramer Sees Opportunity in Stock Trading 10 Off Its Highs Citing Fundamental Strength Anavex AVXL Stock Analysis Falls 438 Watching 279 20260515 What Resolute RHLDs 084 Decline Means for Investors 20260514 Equity Risk Premium Vanishes Yet Retail Investors Stay Bullish